Skip to content

ZAP-X
Clinical
Company
Patient Resources
News & Events
Contact

ZAP-X
Clinical
Company
Patient Resources
News & Events
Contact

- English
- Español
- Français
- Italiano
- 简体字
- 日本語

- English
- Español
- Français
- Italiano
- 简体字
- 日本語

English
Español
Français
Italiano
简体字
日本語

English
Español
Français
Italiano
简体字
日本語

ZAP-X
About ZAP
Contact

ZAP-X
About ZAP
Contact

Self-Shielding Gyroscopic Radiosurgery: A Prospective Experience and Analysis of the First 100 Patients

ZAP-X

ZAP-X® Overview
ZAP-Axon Planning
Installation Sites
Advancing Access
Patient Resources

ZAP-X® Overview
ZAP-Axon Planning
Installation Sites
Advancing Access
Patient Resources

Clinical

Publications
Planning Studies
SRS Webinars

Publications
Planning Studies
SRS Webinars

Company

About ZAP
Leadership
Career Opportunities

About ZAP
Leadership
Career Opportunities

News & Events

Newsroom
Meetings & Tradeshows
Media Resources

Newsroom
Meetings & Tradeshows
Media Resources

Contact

Contact Us

Contact Us

LinkedIn

Instagram

Facebook

Twitter

YouTube

SRS Presentations

Carbon Neutrality Commitment

LinkedIn

Instagram

Facebook

Twitter

YouTube

SRS Presentations

Carbon Neutrality Commitment

LinkedIn

Instagram

Facebook

Twitter

YouTube

SRS Presentations

Carbon Neutrality Commitment

The ZAP-X® Gyroscopic Radiosurgery® platform received U.S. FDA 510(k) clearance in 2017, Japan Shonin clearance in 2020, and E.U. CE clearance in 2021. It is currently not available in all markets. *Based on typical system usage. System shielding requirements may vary by country. ZAP, ZAP-X, the Z symbol, and GYROSCOPIC RADIOSURGERY are registered trademarks of ZAP Surgical Systems, Inc. ©2024 All rights reserved. MK-20526A / ECO-000595. Privacy Policy.

SRS Whole-Brain Dose Matters.

Cognitive deficit hangs in the balance